SCHEDULE 13G/A: UBS Asset Management Amends Clorox Stake Disclosure, Correcting Beneficial Ownership to 0.87%

UBS Asset Management has filed an amended Schedule 13G for The Clorox Company, correcting its reported beneficial ownership to 0.87% due to an inadvertent inclusion of positions from separate reporting entities in its initial filing.

Summary

• UBS Asset Management (UBS AM), a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, and its parent UBS Group AG, filed an Amendment No. 1 to their Schedule 13G for The Clorox Company.
• The amendment corrects an error in the original filing submitted on January 24, 2025, which inadvertently included positions from separate reporting entities that should have been excluded.
• As a result of this correction, UBS AM's aggregate beneficial ownership in Clorox Common Stock is 1,081,801 shares, representing 0.87% of the class.
• UBS AM holds sole voting power over 616,810 shares and shared dispositive power over all 1,081,801 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an initial error occurred, the prompt correction demonstrates good governance and transparency, which is a positive for market integrity. The content itself is purely factual and regulatory.

Positives

• Demonstrates commitment to regulatory compliance and transparency by promptly correcting an error in a public filing.
• Provides accurate and updated information regarding institutional ownership to the market.

Negatives

• The initial filing contained an error, indicating a potential internal data management or reporting oversight.

Risks

• No specific risks related to The Clorox Company's operations or financial health are mentioned in this ownership disclosure.

Future Outlook

NA

Industry Context

This filing is a routine regulatory disclosure by an institutional investor, UBS Asset Management, regarding its passive ownership stake in The Clorox Company. It does not reflect broader industry trends in consumer goods or asset management beyond the standard reporting requirements for significant beneficial ownership.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Provides accurate and updated information regarding institutional ownership, enhancing transparency.
• Regulatory Authorities: Demonstrates compliance with SEC reporting requirements by correcting previous inaccuracies.

Key Dates

Keywords

Clorox, UBS Asset Management, Schedule 13G, beneficial ownership, SEC filing, common stock, institutional ownership, amendment, corporate disclosure